NR3C2 and kidney disorder: Given the fundamental role of mineralocorticoid receptor activation in renal and cardiac fibrosis, effective and selective blocking of the signal with nsMRAs can be used in the clinical practice to prevent or slow down the progression of heart and kidney diseases as demonstrated in several past and more recent studies.104